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Protein phosphorylationand 2 resulted in male chimeras which produced sperm/spermatogenic cells
bearing the mutant allele, however this allele was never transmitted to offspring, indicating infertility due to
haploinsufﬁciency. Morphological defects in chimeras included failure to form elongated spermatids,
apoptosis of spermatocytes and spermatids, and the appearance of numerous round cells in the epididymal
lumen. Characterization of TSSK2 and its interactions with the substrate, TSKS, were further investigated in
human and mouse. The presence of both kinase and substrate in the testis was conﬁrmed, while persistence
of both proteins in spermatozoa was revealed for the ﬁrst time. In vivo binding interactions between TSSK2
and TSKS were established through co-immunoprecipitation of TSSK2/TSKS complexes from both human
sperm and mouse testis extracts. A role for the human TSKS N-terminus in enzyme binding was deﬁned by
deletion mapping. TSKS immunoprecipitated from both mouse testis and human sperm extracts was actively
phosphorylated. Ser281 was identiﬁed as a phosphorylation site in mouse TSKS. These results conﬁrm both
TSSK 2 and TSKS persist in sperm, deﬁne the critical role of TSKS' N-terminus in enzyme interaction, identify
Ser 281 as a TSKS phosphorylation site and indicate an indispensable role for TSSK 1 and 2 in spermiogenesis.
Published by Elsevier Inc.IntroductionThe testis speciﬁc ser/thr kinase family consists of at least 5
members (Spiridonov et al., 2005; Hao et al., 2004; Chen et al., 2005),
several of which have generated interest as candidate male contra-
ceptive drug targets because of their pattern of testicular expression
and the testis speciﬁc expression of the substrate, TSKS. The
nomenclature of the TSSK family was standardized by Manning et
al. (2002). Mouse Tssk1 was cloned by a PCR based strategy searching
for previously unknown kinases using degenerate oligonucleotide
primers for conserved motifs within the kinase catalytic domain
(Bielke et al., 1994). Subsequently, low stringency colony hybridization
with the Tssk1 gene as the probe identiﬁed mouse Tssk2 (Kueng et al.,
1997). A yeast two-hybrid screen led to identiﬁcation of mouse TSKS,
the testis speciﬁc kinase substrate, that formed complexes with TSSK1
and TSSK2 (Kueng et al., 1997). Human homologues of TSSK1 and 2
and TSKS were ﬁrst cloned by Hao et al. (2004).
Murine and human TSSK3were cloned about the same time by two
research groups (Zuercher et al., 2000; Visconti et al., 2001) using PCR
basedmethods. TSSK4 and SSTK (small ser/thr kinase) were discovered
by Blast searches of human and mouse genomes (Spiridonov et al.,
2005; Hao et al., 2004, Chen et al., 2005). TSSK3 can be activated by
PDK1 (phosphoinositide-dependent protein kinase1) through phos-nc.phorylation of the TSSK3 T-loop domain (Bucko-Justyna et al., 2005). A
central transcription factor, cAMP responsive element binding protein
(CREB), was identiﬁed as a TSSK4-interacting protein via a yeast two-
hybrid analysis (Chen et al., 2005). Recently, targeted deletion of Sstk
gene was achieved in mice, resulting in male sterility. A defect in DNA
condensation in Sstk null mutants indicated that SSTK was required
for proper post-meiotic chromatin remodeling and male fertility
(Spiridonov et al., 2005).
Mouse Tssk1 and 2 share high sequence similarity and the same
kinase substrate, TSKS, and thus they may be functionally redundant.
These genes are closely linked on mouse chromosome 16 by an
intergenic region of only 3 kb. This small intergenic region makes
individual targeted deletions of these genes and the creation of a
double knockout by hybridization extremely difﬁcult if not impos-
sible. Thus it was necessary to simultaneously knockout Tssk1 and 2 to
study their functions. Current cDNA array data, which are available
online at http://www.mrg.genetics.washington.edu, show that mouse
Tssk1 and 2 mRNA expression is speciﬁc to spermatids, with the
expression of Tssk1 and 2 in spermatogonia, pachytene spematocytes,
Sertoli cells and myoid cells being lower than the threshold value and
the Tssk2 and Tssk1 mRNA levels being 24 and 16 times higher in
round spermatids than in pachytene spematocytes, respectively.
Therefore, our investigation focused on the role of Tssk1 and 2 in
post-meiotic spermatids and spermatozoa.
In this study, we disrupted one allele of Tssk1 and 2 in mouse
embryonic stem cells derived from the 129Svj strain, and injected the
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breeding of 21 male chimeras resulted in either infertility or only wild
type offspring, due apparently to haploinsufﬁciency. Testes of
chimeras exhibited arrested spermatogenesis, failure to form elon-
gated spermatids, increased apoptosis and increased round sperma-
togenic cells in the epididymides. In order to better understand the
mechanisms underlying this infertility, TSSK2 was characterized in
detail and the interactions between TSSK2 and TSKS in testis and
sperm of humans and mice were studied.
Materials and methods
Construction of targeting plasmids
A targeting vector was designed to delete both Tssk1 and 2 genes (Fig. 1A). This
construct was made based on knockout vector R2-Neo-TK, in which a 6 kb genomic
region including the Tssk1 and Tssk2 coding region and a 3 kb intergenic region was
replaced by a neomycin cassette. The neo gene in this vector served as a positive
selection marker and thymidine kinase served as a negative selection marker. Two FRT
sites were also added at either end of the neo gene. The 5′ and 3′ homology arms of the
targeting vector, 3.5 kb and 5 kb respectively, which were PCR ampliﬁed from mouse
genomic DNA (strain 129Svj), were carefully veriﬁed by restriction mapping and DNA
sequencing to ensure precise sequence identity to optimize targeting efﬁciency.Fig. 1. Targeting deletion of mouse Tssk1 and 2. (A) Schematic representation of the strategy u
genes. Mouse Tssk1 and 2, both intronless genes, are closely linked with one another by an in
and the mutant allele, respectively. X: XbaI, B: BamHI. (B) Southern analysis of the targeted E
wild type (WT) genomic DNA digestedwith XbaI and an additional 6.8 kb knockout band in th
inWTgenomic DNA digestedwith BamHI and an additional 6.5 kb band in themutant allele. (
by chimera BN. The probe 1 detected a single 9.7 kb band in WT genomic DNA digested w
densities. However, in agouti mice sired by the chimera BN only the 9.7 kb wild type bandTransfection of ES cells
The targeting constructs were linearized and puriﬁed, and the linearized plasmids
were electroporated into 129Svj embryonic stem (ES) cells (of proven germline
transmission and bearing XY chromosomes for male germline transmission) cultured
using mouse embryo ﬁbroblast (MEF) feeder cells. Three hundred and ﬁfty colonies
resistant to both neomycin and gancyclovir were selected and expanded.
Genomic DNA extracted from the ES colonies established above was digested by
XbaI, and blotted to hybridization membrane. A 380 bp probe (probe 2, Fig. 1A)
targeting the ﬂanking region of one recombinant armwas utilized to conduct Southern
analysis. To conﬁrm the screening result, genomic DNA extracted from the ES colonies,
which passed the ﬁrst round of screening, was digested by BamHI, and another 1300 bp
probe (probe 1, Fig. 1A) specially targeting the end of the recombinant arm was
employed to conduct second round Southern analysis. The dually positive ES clones
were subcloned to ensure pure lineages.
Generation of mutant mice
Mice were handled according to approved protocols following guidelines of the
Institutional Animal Care and Use Committee (IACUC) of the University of Virginia. Two
ES cell lines bearing deletions of Tssk1 and 2 passed karyotyping analysis, then 10–20
cells at a time were injected into C57BL/6 blastocysts. Blastocysts were transferred to
the uterine horns of 3 day pseudopregnant females for implantation. Chimeric pups
derived from the targeted ES cell lines were identiﬁed by agouti coat color, which differs
from the black background of the C57BL/6 foster mothers. Chimeric male mice thensed to disrupt Tssk1 and 2. Line 1 indicates the genomic structure of the Tssk1 and Tssk2
tergenic region of only 3 kb. Lines 2 and 3 indicate the structure of the targeting vector
S cell clones. The external probe (probe 2, left panel) gave rise to a single 9.4 kb band in
emutant allele. The internal probe (probe 1, right panel) gave rise to a single 9.7 kb band
C) Southern analysis of the tail DNA from three chimeras and three agouti offspring sired
ith BamHI and an additional 6.5 kb band in the chimeras BN, B2 and B3 with different
was detected.
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genotyped by Southern analysis with tail DNA.
Genotyping the sperm and spermatogenic cells from chimeric mice
Sperm and spermatogenic cells were collected from the uteri of C57BL/6 females
following mating with chimeric males. The pellets were treated with proteinase K
(1 mg/ml) with 0.1 M DTT and 2% SDS overnight, and DNA was isolated by standard
phenol/chloroform extraction.
Sperm/spermatogenic cells genotyping was carried out by PCR analysis using the
primers that amplify a microsatellite in the D2Mit94 locus of mouse chromosome 2. The
PCR products were 194 bp for 129Svj and 160 bp for C57BL/6 mice strain (Cho et al.,
2001).
Primers sets were also designed to detect themutant allele. One primerwas speciﬁc
for neo: P1(5′-ggtgagaacagagtacctac-3′); two other primers were speciﬁc to one
homology arm: P2(5′-GCACTGAGTACAAGATCCAGG-3′) and P3(5′-AGAGCCGC-
CGTTAAGAGTCC-3′) as shown in Fig. 1A.
Light microscopy of testis and epididymis
Testes and epididymides were collected from chimeric mice after ﬁxation by
cardiac perfusion with 4% paraformaldehyde. Testes and epididymides were then
further ﬁxed in 4% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate
buffer pH 7.0 at 4 °C overnight. Following parafﬁn embedding and sectioning, the tissue
slides were counterstained with hematoxylin and eosin.
Germ cell apoptosis was examined immunohistochemically with the monoclonal
antibody F7-26 (Apostain; Alexis Corporation, San Diego, CA) directed against single-
stranded DNA (ssDNA). Testes were immersed in Bouins ﬁxative for 6 h, and parafﬁn-
embedded. The Apostain technique was performed according to the protocol described
by Lysiak et al. (2001).
Extraction of sperm proteins and Western analysis
Human semen samples were collected from healthy volunteers. All donors
provided informed consent using University of Virginia Human Investigation
Committee approved forms. After liquefaction of the semen, the mature sperm were
separated from the seminal plasma by washing twice in Ham's F-10 medium. Prior to
the last centrifugation, the cells were counted. The sperm obtained from 8–12
individuals were pooled and frozen immediately until further use. Mouse spermatozoa
were collected from cauda epididymides by allowing the sperm to swim out of minced
caudae in a 1 ml drop of PBS solution for 15 min. Epididymal sperm were washed and
concentrated by centrifugation, and the sperm yield was determined by hemocy-
tometer counting.
Human and mouse sperm pellets were solubilized in Celis lysis buffer (Celis et al.,
1992) containing 2% (v/v) NP-40, 0.1M DTT, 9.8 M urea, and a 10 µl/ml cocktail of
protease inhibitors (Sigma Chemical Company, St. Louis, MO). Sperm cells were
solubilized by constant shaking at 4 °C for 45 min. Insoluble material was removed by
centrifugation at 10,000 ×g for 5 min. Protein concentrations were measured with the
protein assay reagent (Bio-Rad, Inc.). Laemmli sample buffer (Bio-Rad, Inc.) was
added to the protein lysate extracted by Celis buffer. After 5 min of boiling, the
samples were loaded at 80 μg/lane and resolved by 1-D electrophoresis. For 2-D
electrophoresis, sperm protein was extracted by Celis lysis buffer with 0.3%
Ampholines (pH 3.5–10) and 0.2% Ampholines (pH 2.5–5), and ~200 μg of sperm
protein was loaded onto immobilized pH gradient (IPG) strips. First dimension
isoelectric focusing and second dimension SDS-PAGE were performed following the
manufacturer's instructions (Bio-Rad, Inc.).
Sperm proteins separated in 1-D or 2-D gels were electrophoretically transferred to
PVDF membranes. After blocking, the blots were incubated with the polyclonal rat anti-
TSKS serum (Hao et al., 2004) or rabbit anti-TSSK2 serum respectively, at 4 °C overnight,
and then were incubated with enzyme-conjugated secondary antibodies. Horseradish
peroxidase conjugates were visualized by enhanced chemiluminescence (ECL)
(Amersham, Buckinghamshire, UK) and subsequently visualized with the TMB
substrate (Kirkegaard & Perry Laboratories).
Antibody puriﬁcation
Anti-TSKS polyclonal antibodies were puriﬁed using the method described by Rao
et al. (2003) with modiﬁcations. Brieﬂy, puriﬁed human TSKS recombinant protein was
separated on 1-D gels, and electrophoretically transferred to nitrocellulose membrane.
The membrane strip with transferred TSKS was cut out, washed, and blocked with 5%
dry milk in PBS for 1 h. After blocking, the membrane was incubated overnight at 4 °C
with anti-TSKS antiserum. Then, the membrane strip was washed, and was eluted with
elution buffer (Pierce) for 5 min at 22 °C. The eluted sample was immediately
neutralized by adding 1 M Tris–HCl (pH 8.0), and was dialyzed against PBS at 4 °C. The
resulting afﬁnity-puriﬁed antibodies were stored at 4 °C.
Characterization of interactions between human TSSK2 and human TSKS in a yeast
two-hybrid system
The entire open-reading frame (ORF) of human TSSK2 was fused with the GAL4
DNA binding domain (DBD) and a myc tag in frame in the pGBKT7 two-hybrid vector(Match-Maker yeast two-hybrid reaction kit, Clonetech). The entire ORF of human TSKS
and a series of deletion mutants of various TSKS domains (Fig. 6) were fused with the
GAL4 DNA activation domain (AD) with a HA tag in frame in pGADT7. After conﬁrmation
of correct sequence alignment by DNA sequencing, plasmid pairs containing TSSK2 and
TSKS were introduced into the yeast two-hybrid host strain AH109 by co-transforma-
tion and selected for both nutritional markers carried on the two plasmids. Single
colonies containing all plasmid pairs were tested for their ability to grow on medium
selective for the histidine reporter gene as well as for color formation (using alpha-
galactosidase). Single colonies were inoculated in liquid medium, and the expression
levels of alpha-galactosidase were quantiﬁed according to the method described
previously (Hao et al., 2004). Binding strengths have been shown to be linearly related
to expression levels of alpha-galactosidase (Clonetech). The seven deletion mutants
were: D1 Δ 392–592; D2 Δ 326–592; D3 Δ 1–48; D4 Δ 1–147; D5 Δ 1–234; D6 Δ 1–261;
and D7 Δ 234–392.
Immunoprecipitation
Immunoprecipitation was performed by protein G following the manufacturer's
instructions (Immunoprecipitation Kit, Roche Molecular Biochemicals). The starting
biological samples were: 1.5×109 washed human sperm, or 4 decapsulated mouse
testes. These samples were homogenized in pre-chilled lysis buffer. The lysate was then
cleared by centrifugation at 12,000 ×g for 20 min at 4 °C. Protein concentrations were
measured with the Bio-Rad protein assay reagent, and adjusted to 15 µg/µl. To reduce
background, 50 µl of protein-G agarose suspension was added to each milliliter of
protein extract and incubated for 3 h at 4 °C on a rocking platform. The resultant pre-
cleared protein extracts were then incubated with an appropriate amount of anti-TSKS
rat serum or anti-TSSK2 rabbit serum for 2 h. Subsequently, 50 µl of protein-G agarose
suspension was added to each milliliter of protein extract and rocked overnight at 4 °C.
The agarose pellets were collected and washed in lysis buffer twice, and in 10 mM Tris
buffer, pH 7.5, twice. For protein gel electrophoresis, Laemmli loading buffer was added
to the agarose pellets. After boiling for 5 min, the samples were loaded on SDS-PAGE
gels. Normal rat and rabbit sera were used as immunoprecipitation controls.
In vitro kinase assay
TSKS/TSSK complexes immunoprecipitated from human sperm protein extracts or
mouse testis protein extracts were subjected to in vitro kinase assay by incubating
complexes bound to protein-G agarose beads in a kinase assay buffer described by Hao
et al. (2004) and 5 µCi [32P]γATP in a volume of 20 µl at 37 °C for 20 min. The reaction
was stopped by adding 20 µl of 2× Laemmli sample buffer, and reaction products were
subjected to SDS-PAGE. After staining with Coomassie dye to conﬁrm equal loading, gels
were dried and autoradiographed to detect phosphorylation.
Phosphorylation sites mapping by IMAC-LC-MS/MS
Immune complexes immunoprecipitated with anti-TSKS (IP-TSKS) were submitted
for phosphopeptide analysis by IMAC-LC-MS/MS. Fe3+-immobilized metal afﬁnity
chromatography (IMAC) was employed to enrich the digest for peptides containing
phospho-amino acids. To decrease nonspeciﬁc binding to the IMAC column, acidic
residues were converted to esters before binding. Eluent from the IMAC column was
directly analyzed in an LC-MS/MS system consisting of a Thermo Electron LTQFT mass
spectrometer interfaced with a Protana nanospray ion source and a C18 reversed-phase
capillary column. The TSKS IP digest was analyzed using the double play capability of
the instrument acquiring a full scan mass spectrum to determine peptide molecular
weights followed by sequential product ion spectra (ten) to determine amino acid
sequences. This mode of analysis produces many MS/MS spectra of ions ranging in
abundance over several orders of magnitude. The MS/MS data were then analyzed by
database searching using the Sequest search algorithm against TSKS. Putative
phosphopeptides were manually veriﬁed.
Results
In addition to Tssk1–4 and Sstk reported previously in the mouse
genome (Chen et al., 2005; Spiridonov et al., 2005; Zuercher et al.,
2000; Visconti et al., 2001; Kueng et al., 1997), a putative Tssk5
(NP_898922) located on chromosome 15 is now listed in the NCBI
database. All six Tssk genes are located on somatic chromosomes. A
maximal parsimony tree (Supplemental Fig. 1) which depicts
phylogenetic relationships between protein members of the mouse
TSSK family was generated. It was noted that TSSK1 and 2 form a
closely related clade (100% certainty score). Both TSSK1 and TSSK2
have a conserved kinase domain while also having unique carboxyl
terminal extensions. Tssk1 and Tssk2 are intronless genes linked to
each other with an intergenic region of only 3 kb, implying one is a
retrogene duplicated from an ancestral Tssk by a retroviral mechanism
during evolution, while the other may have resulted from duplication
of the retrogene. A recent study of primate genomes reported that the
Fig. 2. PCR genotyping of chimeric testes and epididymides (A) and sperm/
spermatogenic cells collected from uteri of females mated with male chimeras (B).
PCR for mutant alleles is shown in panels 1 and 2 and 4 and 5. PCR to detect the 129Svj
(194 bp) and C57BL/6 (160 bp) microsatellite DNA at D2Mit94 locus is shown in panels 3
and 6. (A) The mutant alleles were not detected in wild type testis and epididymides
(WTT and WTE), but were detected in DNA from the chimeric testes (B2T, BNT) and
epididymides (B2E, BNE and BDE), consistent with the detection of both 129Svj and
C57BL/6 genomes in the samples from chimeric mice. (B) The mutant alleles were also
detected in several DNA samples (B2, B3) from sperm/spermatogenic cells collected
after mating chimeric mice (panels 4 and 5), consistent with detection of both 129Svj
and C57BL/6 microsatellite DNA at the D2Mit94 locus (panel 6).
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their parental genes show broad expression patterns, suggesting these
retrogenes may involve enhancing male germline function (Marques
et al., 2005).
Generation of Tssk1 and 2 knockout allele
Because of the proximity of Tssk1 and Tssk2 onmouse chromosome
16 (only 3 kb separate Tssk1 from Tssk2), it is nearly impossible to
approach targeting these genes with the conventional strategy of
creating separate knockouts of Tssk1 and Tssk2 and then establishing
the double knockout by crossing. Also, because Tssk1 and 2 share high
sequence similarity as well as the same kinase substrate, probably
arising from gene duplication, it is highly likely that they are
functionally redundant. Therefore, a simultaneous double knockout
of Tssk1 and 2 was performed (Fig. 1A). The knockout construct was
electroporated into mouse ES cells (129Svj strain), and double
selection was used to identify targeted clones.
Correct targeting was veriﬁed by Southern blot analyses using
external and internal probes. An external 380 bp probe (probe 2, Fig.
1A) for the ﬂanking region of one homology arm was utilized to
conduct Southern hybridizationwith XbaI digested genomic DNA. The
presence of a 6.8 kb knockout band in addition to a 9.4 kb wild type
band indicated that homologous recombination had interrupted one
copy of the Tssk1 and 2 genes, resulting in heterozygous ES cell lines
(Fig. 1B, left panel). This result was conﬁrmed with a second Southern
using BamHI digested genomic DNA from the ES colonies and an
internal 1300 bp probe (probe 1, Fig. 1A) located at the end of one
homology arm. The presence of a 6.5 kb knockout band in addition to a
9.7 kb wild type band further conﬁrmed that homologous recombina-
tion had interrupted one copy of the Tssk1 and 2 genes (Fig. 1B, right
panel). The positive ES clones, #89, #93, carrying veriﬁed targeting
deletions were subcloned to ensure pure lineages and injected into
blastocysts derived from the C57BL/6 strain.
A total of 34 chimeric mice were obtained; 21 of them were male,
including 10 high-percentage chimeric (HPC) males (estimated by fur
color mosaicism) and 11 low-percentage chimeric (LPC) males.
Southern analysis of tail DNA showed the presence of 6.5 kb knockout
bands in addition to 9.7 kbwild type bands, indicating that the correct
mutant allele integrated into the chimeras (Fig. 1C, chimeras BN, B2
and B3). The intensity of the knockout bands vs. wild type bands
varied in tail DNA retrieved from chimeras, and was consistent with
their variable percentage of agouti fur color.
Twenty one chimeric males were mated with C57BL/6 wild type
female mice. During 6–10 months of intensive breeding during which
those mice that were fertile had more than 10 litters, the following
outcome was observed: 4 HPC and 1 LPC were completely infertile; 6
HPC were fertile but only sired wild type black offspring; and ten LPC
were also fertile but only sired wild type black offspring.
In only one instance, were agouti pups produced: 8 agouti pups
resulted from a total of 99 offspring from one LPC. Southern
techniques were used to identify if heterozygous (+/−) mice were
among the agouti offspring. Surprisingly, none of these agouti mice
were heterozygous. Although the genotype of the chimeric father
(BN) clearly had integrated the targeted mutant allele (Fig. 1C, BN),
all offspring were wild type (Fig. 1C, A1, A2, A3 show three repre-
sentative genotypes of these agouti mice). In contrast, it was
predicted that 50% of these agouti mice would be heterozygous
while there is only a 1 in 256 chance of having no heterozygotes
within 8 agouti offspring.
Genotyping the testis, epididymis and sperm from chimeric males
conﬁrmed germline transmission
The testes and epididymides were collected from wild type (WT)
as well as the chimeric males, DNAwas extracted, and PCR genotypingwas conducted using three sets of primers: 1) a neo-Tssk primer set 1
(shown in Fig. 1A, P1 with P2) produced a 420 bp DNA fragment
representing the mutant allele; 2) a neo-Tssk primer set 2 (shown in
Fig. 1A, P1 with P3) ampliﬁed a 350 bp band also representing the
mutant allele; and 3) microsatellite primers targeting the D2Mit94
locus of mouse chromosome 2 were designed to PCR amplify 194 bp
and 160 bp bands representing the microsatellite polymorphism of
D2Mit94 loci in 129Svj and C57BL/6 strains, respectively. As shown in
Fig. 2A, 420 and 350 bp bands representing the mutant allele were
detected in the testes and epididymides of chimeric mice (e.g. B2, BN
and BD in panels 1 and 2 in Fig. 2A). This result was further supported
by the detection of both C57BL/6 and 129Svj microsatellite poly-
morphisms at the D2Mit94 loci (same three chimeras B2, BN and BD in
panel 3 in Fig. 2A). Neither the mutant allele nor the 129Svj D2Mit94
locus was detected in wild type mice.
In order to further characterize this phenotype, sperm/spermato-
genic cells from the chimeric and wild type males were collected from
uteri after mating with C57BL/6 females (e.g. chimeras B1, B2, B3, B47,
BD and WT in Fig. 2B) and were genotyped with the set of primers
described in the preceding paragraph. The 420 and 350 bp bands
representing the mutant allele were clearly detected in sperm/
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in Fig. 2B) and both C57BL/6 and 129Svj type genomes were present.
Neither the mutant allele nor the 129Svj D2Mit94 locus was detected
from the wild type mouse and chimera B47.
A faint band representing the mutant allele was detected in the
B1 (panel 4 in Fig. 2B) and BD (panel 5 in Fig. 2B) chimeras, however
PCR ampliﬁcation of microsatellite DNA of D2Mit94 locus failed due
to limited amount of DNA extracted from the uterine ﬂushing. In fact,
the chimera B1 was an infertile mouse, it only formed a plug in one
female mouse in 5 mating experiments, and only a few sperm were
observed in the uterine ﬂushing. Biopsy of testis and epididymis of
B1 indicated that very few sperm reached maturation, and only a few
round spermatogenic cells occupied the lumen of the epididymis
(Figs. 3C and D). Thus very few sperm/spermatogenic cells could be
collected from this chimera.
In addition to the chimeras shown in Fig. 2B, a total of 10 chimeric
males from 21 tested chimeric males produced sperm/spermatogenic
cells bearing the mutant allele and 129Svj type of D2Mit94 locus.
These ﬁndings conﬁrmed that germline transmission of the mutant
allele did occur and that chimeric mice were producing 129Svj type
sperm/spermatogenic cells. Among these 10 chimeras, 6 of themwereFig. 3. Histological analysis of testes and epididymides from wild type and chimeric m
spermatogenesis (A) and spermatozoa ﬁll the epididymal lumen (B). (C to F) Light microgr
morphology in testes from chimera B1 (C) is characterized by the absence of elongated spe
chimera B1 is characterized by the absence of sperm and the presence of numerous round ce
tubule (in the central) with no evident germ cells is accompanied by a few tubules showin
Vacuoles and degenerating symplast-like cells were found in one seminiferous tubule surrohigh-percentage chimeras including infertile B1 (judging from the fur
color, B1 is more than 95% chimera); 4 of them were low-percentage
chimeras including BN which produced 8 agouti offspring.
Thus, the targeted allele was transmitted into the germline and
into sperm/spermatogenic cells of these chimeric males but only wild
type offspring resulted. Identical results were obtained from chimeric
mice generated from two independent ES clones. These results
indicate that targeted deletion of one copy of Tssk 1 and 2 genes
causes haploinsufﬁciency which leads to male infertility.
To rule out the possibility that the deletion of Tssk1 and 2 caused
the arrest of early embryonic development instead of male infertility,
the litter sizes produced by 10 chimeric mice with evidence of
germline transmissionwere compared with those of 7 fertile chimeric
mice without detectable germline transmission. In the experimental
group, except for infertile mouse B1, the average litter sizes for
individual males range from 5.65 to 8.25, and the mean of average
litter size for this group was 6.54, which was not signiﬁcantly different
than the control group, where the average litter size for each male
ranged from 5.93 to 8.23, and the mean of average litter size for the
control group was 6.67. Therefore, it is unlikely that the deletion of
Tssk1 and 2 led to early embryonic lethality.ice. Testes and epididymides from wild type C57BL/6 mice show normal stages of
aphs of testes (C, E and F) and epididymides (D) from three chimeric mice. Abnormal
rmatids from most seminiferous tubules. Abnormal morphology in the epididymis of
lls in the epididymal lumen (D). (E) Abnormal morphology of testes from chimera BN. A
g apparently normal spermatogenesis. (F) Abnormal testis morphology of chimera BD.
unded by tubules with normal morphology.
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Histological analyses focused on the testes and epididymides
from 10 male chimeras in which both integration of ES cells into the
testis and production of sperm/spermatogenic cells bearing the
mutant allele had been conﬁrmed by PCR. These testes showed a
range of altered testicular morphologies. For example, in a HPC
(N95%) mouse, which was entirely infertile, both testes were small
(b50% of wild type in weight and size), and 98% of the seminiferous
tubules displayed severely altered spermatogenesis (Fig. 3C) with an
absence of elongating and elongated spermatids, lack of testicular
sperm in the tubule lumen and the presence of round cells rather
than spermatozoa in the epididymal lumen (Fig. 3D). 2 HPC and 2
LPC had increased numbers of abnormal seminiferous tubules, 19.2%,
8.9%, 11.5%, 9.2% tubules being disrupted in this group, compared
with age-matched wild type mice in which the mean incidence of
abnormal tubules was 2.8%. Along with this increased incidence of
abnormal seminiferous tubules in chimeric mice, increased numbers
of round cells were observed in the epididymal lumen compared to
age-matched wild type controls. In the abnormal seminiferous
tubules from these 5 animals, spermatogenesis was arrested before
step 7. Sixty three percent of these abnormal seminiferous tubules
had early spermatids up to step 7, but lacked elongating and
elongated spermatids. Twenty eight percent of the abnormal
seminiferous tubules had spermatogonia and spermatocytes and
lacked spermatids, while 9% showed the “Sertoli-only” phenotype
with very few spermatogonia. The severely disrupted tubules often
had multiple vacuoles and aggregated germ cells (the central tubules
in Figs. 3E and F). Thus, a full complement of TSSK1 and 2 proteins
may be essential for spermiogenesis after step 7, when the critical
processes of ﬂagellar formation and nuclear condensation occur.
Since cDNA array data (http://www.mrg.genetics.washington.edu)
indicate that both Tssk1 and Tssk2 are expressed only in spermatids,
a ﬁnding conﬁrmed by the immunolocalization of Tssk2 in our
companion paper (Xu et al, 2008), it is posited that more severe and
earlier arrest in some of the tubules may be caused by the arrest ofFig. 4. Immunohistochemical examination of germ cell apoptosis in chimeric testes. (A) Repre
Numerous apoptotic germ cells (arrows) are present in a chimeric testis. (C and D) Sperma
apoptosis in chimeric testes.spermatid development which disrupt the cellular communication
between germ cells.
Apoptosis in chimeric testes
Another 3 HPC and 2 LPC which produced sperm/spermatogenic
cells bearing the mutant allele had only a few obvious abnormal
seminiferous tubules (b5%), which was not statistically different from
the incidence of abnormal tubules observed in the wild type mice
(2.8%), and very few round cells were noted in the epididymal lumen
of these chimeras. Despite the lack of obvious morphological
disruption of the stages of the seminiferous cycle, differences were
noted, when the testes from these animals were subjected to
apoptosis analysis. As shown in Fig. 4, testis sections from the wild
type mice revealed very few apoptotic nuclei (Fig. 4A); spermatogonia
were the major cell type among those undergoing apoptosis and the
apoptotic cells were interspersed with normal cells (data not shown).
Sections from chimeric mice, on the other hand, showed a 6 to 8.5 fold
increase in the number of apoptotic nuclei (Fig. 4B). Spermatocyte
(Figs. 4C and D, arrow) and early round spermatid nuclei (Figs. 4C and
D, arrowhead) were the predominant cell types undergoing apoptosis
in chimeric mice, and the apoptotic cells often appeared in clusters
(Figs. 4C and D), consistent with the interpretation that the apoptotic
cells represented clonally derived daughter cells. Thus, although the
stages of spermatogenesis appeared morphologically intact in this
group of chimeras, cohorts of spermatocytes and early spermatids
underwent markedly increased apoptosis compared to the wild type
controls. These ﬁndings indicate that increased apoptosis occurs as a
result of the lower dose of TSSK1 and 2, which appears to be critical for
spermatogenesis.
Presence of TSSK2 and TSKS proteins in mature mouse and human
spermatozoa
The failure of Tssk1 and 2 chimeras to propagate the null allele and
the arrest of spermatogenesis at the spermatid stage prompted us tosentative testis section from awild type C57BL/6mouse showing few apoptotic cells. (B)
tocytes (arrows) and round spermatids (arrowheads) are major cell types undergoing
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TSSK1 and TSSK2 have high similarity and share the same substrate
TSKS, the study focused on one of the kinases, TSSK2, and the
interaction of TSSK2 with TSKS.
TSSK1 and 2 and TSKS proteins were previously reported (Kueng et
al., 1997) to be abundant in mouse testis, but absent in the epididymis
where sperm undergo ﬁnal maturation and storage. However, in this
studywith 80 μg testis or sperm proteins loaded in each lane, antibody
to mouse TSSK2 detected 41 kDa TSSK2 not only in mouse testis
extracts but also in mouse epididymal sperm (Fig. 5D), and 42 kDa
TSSK2 in human ejaculated sperm extracts (Fig. 5A). Pre-immune sera
resulted in only a very faint background. These Western results
differed from previous reports which showed no TSSK2 in sperm
(Kueng et al., 1997). The present demonstration differed methodolo-
gically from the previous report in that Celis buffer was employed in
the present extraction protocol, which may have been more efﬁcient
in extracting immunoreactive TSSK2 from sperm.
To generate a speciﬁc immunoreagent, recombinant human TSKS
was expressed in E. coli, puriﬁed, and employed to generate polyclonal
antibodies in rats. The anti-TSKS antibodies immunoreacted with both
human and mouse TSKS (Fig. 5, indicated by arrows), which are 83%
identical at the amino acid level. In protein extracts from human
sperm, the anti-TSKS antibody recognized a single 65 kDa band, which
is the predicted size of full length human TSKS (Fig. 5A, left pair), as
previously published for human testis (Hao et al., 2004). Control pre-
immune serum did not recognize any proteins in the sperm extracts.
This is the ﬁrst demonstration that TSKS is found in ejaculated human
sperm.
In addition to the reported humanTSKS sequence (Hao et al., 2004),
an alternative splice variant of human TSKS was detected by cDNA
cloning from human testis Marathon-ready cDNA (Clontech) [nowFig. 5.Western blot analyses of TSKS and TSSK2 protein expression in testes and spermatoz
TSKS and 42 kDa TSSK2, respectively, on 1-D Western blots of human sperm protein extrac
stained with rat anti-TSKS or corresponding pre-immune sera. A broad TSKS band at ~60 kDa
was the major isoform detected in epididymal spermatozoa. Pre-immune control serawere n
mouse testis, ~60 kDa TSKS showed protein microheterogeneity with both mass and charge
(lower panel) in mouse sperm. (D) Protein extracts from mouse testis and epididymal sperm
both mouse testis and sperm by the immune sera, while pre-immune sera were negative.listed in theNCBI databasewith accessionnumberAF411384].Whereas
the full length human TSKS has 592 aa, the variant lacks the ﬁrst 5
exonswhile retaining exons 6–10 and adds a uniqueﬁrst exon, yielding
a predicted 42.3 kDa protein of 386 aa which, interestingly, did not
appear in human sperm extracts in Western analyses (Fig. 5A).
In mouse testis extracts (Fig. 5B) anti-TSKS antibody recognized a
broad band at ~60 kDa, as well as a band of ~40 kDa, which we refer to
truncated TSKS, or TSKSt. The ~60 kDa TSKS was the major isoform
detected in mouse testis, while the ~40 kDa TSKSt was the major
isoform in mouse epididymal spermatozoa (Fig. 5B) where the
~60 kDa TSKS was undetectable at 80 μg sperm protein/lane. The
current NCBI database lists two mouse TSKS cDNAs, NM_001077591
and NM_011651, that encode 57.3 and 63.5 kDa proteins, respectively,
the former having a 9 aa deletion in the middle (exon 5) and an
additional 51 aa deletion at C-terminus (exon 11). The ~60 kDa TSKS
may be encoded by one or both of these variants.
Three lines of evidence argue that the ~60 kDa and ~40 kDa
proteins in Fig. 5B are both authentic mouse TSKS isoforms. 1) As
shown below, anti-TSKS antibody was employed to immunoprecipi-
tate TSKS from mouse testis extracts, the immunoprecipitated
products were submitted for mass spectrometry, and multiple
peptides covering 221 aa of mouse TSKS were detected. 2) To establish
the immunological identity of the ~60 kDa and ~40 kDa proteins as
authentic TSKSs, an afﬁnity-puriﬁed antibody to TSKS was generated
through binding and eluting antibody from recombinant TSKS protein.
This afﬁnity-puriﬁed antibody recognized the ~60 kDa and ~40 kDa
TSKS protein frommouse testis and spermon1-Dgels. 3) This antibody
revealed considerable TSKS protein microheterogeneity. High resolu-
tion 2-D gel immunoblots of ~60 kDa TSKS isoforms frommouse testis
showed charge trains, as well as three slight mass variants, indicating
possible phosphorylation at multiple sites as well as other post-oa from mouse and human. (A) rat anti-TSKS or rabbit anti-TSSK2 sera detected 65 kDa
ts. (B) Protein extracts from mouse testis and epididymal sperm on 1-D Western blots
and a ~40 kDa truncated TSKS [TSKSt] were noted in testis extracts. The ~40 kDa TSKSt
egative. (C) Charge and mass variants of TSKS in 2-DWestern blots indicated that, in the
variants (upper panel), while ~40 kDa TSKSt showed charge variants at a single mass
on 1-D Western blots stained with rabbit anti-TSSK2, 41 kDa TSSK2 was recognized in
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extracted from mouse sperm exhibited protein microheterogeneity
with a prominent charge train at one consistent mass, a feature of
phosphorylated proteins (Fig. 5C).
The ﬁnding of several mass variants of ~60 kDa TSKS on 2-D blots is
consistent with the broad TSKS band observed on 1-D Western blots.
The 57.3 and 63.5 kDa mouse TSKS variants mentioned above may be
responsible for the mass variants of ~60 kDa TSKS shown in Fig. 5C.
The ~40 kDa mouse TSKSt protein may be encoded by an unknown
splicing variant of TSKS or could represent a proteolytic product. As
noted in our companion paper, a population of TSKS was localized in
the residual cytoplasm of late stage spermatids where proteolysis may
cause the formation of truncated TSKS.
The essential interacting domain of human TSKS with TSSK2
We previously reported that human TSKS strongly interacts with
TSSK2 in yeast two-hybrid analyses (Hao et al., 2004). To dissect the
essential domain(s) required for TSKS interaction with TSSK2,
bioinformatic analyses were ﬁrst performed. A number of interesting
structural motifs were noted within human TSKS. These included a
putative nuclear localization signal (NLS, aa 48–51), two coiled-coil
domains (C–C1, aa 147–234; C–C2, aa 324–392), and three 6 amino
acid repeats (Rpt), QEPEEK, located at aa 244–261 (Fig. 6A). Based on
these analyses, a total of 7 deletion mutants of TSKS were created (Fig.
6A). The 7 deletion mutants (namely D1 to D7) were fused with the
Gal4 activation domain in the pGAD, and their expression in the two-
hybrid host strain was ﬁrst tested by Western blot analysis (Fig. 6B).
These fusion proteins were then tested for their ability to interact withFig. 6. Analysis of the essential domains of humanTSKS required for interactionwith TSSK2. (A
putative coiled-coil domains [C–C1, C–C2], the six amino acid repeats (Rpt) and the amino ter
were created and fused with the Gal4 activation domain in the pGAD two-hybrid vectors. Fu
into the yeast host strain AH109. (B) The expression of the fusion proteins of each mutant w
alpha-galactosidase activity. The activity shown by each deletionmutant is expressed as the p
A. The N-terminus of TSKS is crucial to its interaction with TSSK2. Error bars indicate variatTSSK2 fused with pGBD. A quantitative analysis of the reporter gene
activity (alpha-galactosidase) was performed (Fig. 6C). The activity
shown by each mutant is expressed as the percentage of wild type
TSKS (Fig. 6C) adjacent to the corresponding deletionmutant (Fig. 6A).
In mutant D1 (Δ 392–592), which represented a deletion of a major
part of the TSKS C-terminus, TSSK2 binding was reduced by 43%. In
mutant D2 (Δ 326–592), inwhich both the C-terminus and the second
coiled-coil domain were deleted, TSSK2 binding was reduced by 68%.
Thus, some TSSK2 binding persisted in the absence of the second
coiled-coil region. In mutant D7 (Δ 234–392) where the second
coiled-coil domain and the region between the two coiled-coil
domains, including the six amino acid repeat motif, were absent but
the C-terminus was intact, binding was close to wild type levels. This
indicated that the second coiled-coil domain and the six amino acid
repeats play no role in TSSK2 binding, and suggested that the C-
terminus may play some role in TSSK2 interaction but is not the
critical binding site. Deletion of the ﬁrst 48 amino acids (D3) reduced
TSKS binding to 5% while deletion of the ﬁrst 147 amino acids (D4, D5,
D6) abolished TSKS binding entirely. These results showed that the N-
terminus of TSKS is essential for its interaction with TSSK2.
Co-immunoprecipitation (IP) of TSKS/TSSK2 complexes from human
sperm
To test whether in vivo interactions between TSKS and TSSK2
occurred in ejaculated human sperm, co-immunoprecipitation experi-
ments were performed. Pre-cleared protein extracts from human
sperm were immunoprecipitated with rabbit anti-TSSK2 serum (IP-
TSSK2) or control normal rabbit serum (Rabbit IP-control). The) Schematic drawing of TSKS ORF highlighting knownmotifs and deletionmutants. Two
minal nuclear localization signal (NLS) are marked. A total of 7 deletion mutants of TSKS
sion proteins of each mutant and the Gal-AD were co-transformed with Gal-DBDTSSK2
as analyzed by Western analysis. (C) Culture supernatants of each pair were assayed for
ercentage of wild type (WT) TSKS. The corresponding deletion mutant is shown in panel
ion among 3 experiments.
Fig. 7. Co-immunoprecipitation and in vitro phosphorylation of TSKS/TSSK2 complexes from human sperm. Panels 1 and 2: pre-cleared human sperm extracts were
immunoprecipitatedwith either control rabbit serum (Rabbit IP-control) or rabbit anti-TSSK2 serum (IP-TSSK2), and the immunoprecipitates were subjected to immunoblotting with
anti-TSSK2 (panel 1) or anti-TSKS (panel 2). 65 kDa and ~50 kDa TSKS isoformswere recognized by anti-TSKS antibody only in the lane immunoprecipitatedwith anti-TSSK2 antibody
while 42 kDa TSSK2 was detected in the immunoprecipitate. Panels 5 and 6: pre-cleared human sperm extracts were immunoprecipitated with either pre-immune rat serum (Rat IP-
control), or rat anti-TSKS serum (IP-TSKS), the immunoprecipitates were subjected to immunoblotting with anti-TSKS antibody (panel 5) or anti-TSSK2 antibody (panel 6). 65 kDa
TSKS and 42 kDa TSSK2 were detected only in the lanes immunoprecipitated with anti-TSKS. Panels 3 and 4: autoradiograph of TSSK2/TSKS complexes immunoprecipitated with
either anti-TSSK2 (IP-TSSK2) or anti-TSKS (IP-TSKS) and incubated with [32P]γATP. Four identical phospho-protein bands were detected in immune complexes precipitated with
either anti-TSSK2 (IP-TSSK2) or anti-TSKS (IP-TSKS). Conversely, no proteins were phosphorylated in the controls immunoprecipitated with normal sera (Rabbit IP-control and Rat IP-
control). These bands represent phosphorylation of 65 and ~50 kDa forms of TSKS, autophosphorylation of TSSK2 and an unknown 30 kDa phospho-protein.
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anti-TSSK2 antibody (Fig. 7, panel 1) or rat anti-TSKS antibody (Fig. 7,
panel 2). Immunoprecipitates from human sperm brought downwith
rabbit anti-TSSK2 antibody contained two bands only in the IP-TSSK2
lane at ~65 kDa and ~50 kDa that were recognized by anti-TSKS
antibody (Fig. 7, panel 2). No bands were recognized by anti-TSKS
antibody in the rabbit IP-control lane. This conﬁrmed that immuno-
precipitation of TSSK2 from human sperm brought down its substrate,
TSKS. As a positive control, immunoblotting with anti-TSSK2 con-
ﬁrmed that the immunoprecipitates indeed contained TSSK2, which
migrated at ~42 kDa only in the IP-TSSK2 lane (Fig. 7, panel 1). In panel
1, background heavy and light chain (arrowheads) immunoglobulin
bands were present due to the reactivity of the goat anti-rabbit
secondary antibody with the rabbit anti-TSSK2 antibody or normal
rabbit serum used in the IP reaction.
The converse experiment gave similar results. Precleared protein
extracts from human spermwere immunoprecipitated using rat anti-
TSKS serum (IP-TSKS) and normal rat serum (Rat IP-control). The
immunoprecipitates were subjected to immunoblotting with anti-
TSKS antibody (Fig. 7, panel 5) or anti-TSSK2 antibody (Fig. 7, panel 6),
respectively. The immunoblots with anti-TSKS conﬁrmed the immu-
noprecipitation of ~65 kDa TSKS from human sperm protein extracts
only in the lane containing the anti-TSKS immune complexes and not
in the lane precipitated with control rat serum (Fig. 7, panel 5). The
~50 kDa TSKS form could not be conclusively identiﬁed due to
possible masking by the ~50 kDa heavy chain band. The immunoblot
with anti-TSSK2 showed a band in the IP-TSKS lane at ~42 kDa (Fig. 7,
panel 6), the predicted size of human TSSK2, while this band was not
evident in the lane immunoprecipitated with control rat sera.
Together these experiments demonstrated that both rabbit anti-
TSSK2 and rat anti-TSKS immunoreagents were capable of precipitat-
ing complexes containing both TSSK2 and TSKS from human sperm.
This conﬁrmed in vivo interactions of this kinase/substrate pair in
mature human sperm.
In vitro phosphorylation of TSKS
Immune complexes precipitated from human sperm extracts with
either anti-TSKS (IP-TSKS) or anti-TSSK2 (IP-TSSK2) were incubated
with [32P]γATP (Fig. 7, panels 3 and 4). Four phosphorylated bands
were detected in complexes immunoprecipitated with anti-TSSK2(Fig. 7, panel 3), while the same four bands were detected in
complexes immunoprecipitated with anti-TSSK2 (Fig. 7, panel 4).
These phosphorylated bands did not appear in lanes immunopreci-
pitated with either control serum. Based on their alignment with the
immunoblots to either side, these bands represent 65 kDa TSKS, the
~50 kDa truncated TSKS (also seen in Fig. 7, panel 2), 42 kDa TSSK2 and
an unknown ~30 kDa protein. Since this ~30 kDa protein appeared in
immunoprecipitates with both TSKS and TSSK2 antisera but not in
controls, it is potentially a new phospho-protein constituent of the
TSKS/TSSK2 complex or a proteolytic fragment of either kinase or
substrate. This experiment conclusively demonstrated that TSSK2 in
human sperm is enzymatically active and capable of phosphorylating
TSKS.
Co-immunoprecipitation (IP) of TSSK2 and TSKS from mouse testis and
in vitro phosphorylation of mouse testicular TSKS
TSSK2 and TSKS co-immunoprecipitation experiments were also
conducted with protein extracts from mouse testis. Precleared testis
extracts were immunoprecipitated using normal rabbit serum (Rabbit
IP-control), or rabbit anti-TSSK2 serum (IP-TSSK2), and the immune
complexes were subjected to immunoblotting with anti-TSSK2 or
anti-TSKS antibodies, respectively (Fig. 8, panels 1 and 2). Anti-TSSK2
antibodies immunoprecipitated 41 kDa TSSK2 as well as ~60 kDa TSKS
and ~40 kDa TSKSt from mouse testis protein extracts, whereas
control sera did not immunoprecipitate these proteins (Fig. 8, panels 1
and 2). Conversely, anti-TSKS antibodies immunoprecipitated TSKS
and TSSK2 proteins from mouse testis, while the control sera did not
(Fig. 8, panels 3 and 4). This veriﬁed that both anti-TSKS and anti-
TSSK2 antibodies are capable of co-immunoprecipitating TSKS and
TSSK2 from mouse testis.
In vitro phosphorylation of immune complexes immunoprecipi-
tated with either anti-TSKS (IP-TSKS) or rat normal serum (IP-control)
from mouse testis were subsequently incubated with [32P]γATP in an
in vitro kinase assay (Fig. 8, panel 5). A common kinase, casein kinase 2
(CKII) and several common kinase substrates including casein, myelin
basic protein (MBP) and histone 3 were added to the reactions as
positive controls. In the immunoprecipitates with anti-TSKS sera, TSKS
was strongly phosphorylated as well as a ~40 kDa protein, while no
proteins were phosphorylated by immune complexes precipitated
with control normal rat sera. The ~40 kDa protein may represent
Fig. 8. Co-immunoprecipitation and in vitro phosphorylation of TSKS/TSSK2 complexes from mouse testis. In panels 1 and 2, pre-cleared mouse testis extracts were
immunoprecipitated with either rabbit normal serum (Rabbit IP-control), or rabbit anti-TSSK2 serum (IP-TSSK2), and the immunoprecipitates were subjected to immunoblotting
with anti-TSSK2 (panel 1) or anti-TSKS (panel 2). TSKS and TSSK2 were both detected in the immune-complex immunoprecipitated with anti-TSSK2 serum. In panels 3 and 4,
precleared mouse testis extracts were immunoprecipitated with either normal rat serum (Rat IP-control), or rat anti-TSKS serum (IP-TSKS), and the immunoprecipitated complexes
were subjected to immunoblotting with anti-TSKS (panel 3) or anti-TSSK2 antibody (panel 4). Both TSKS and TSSK2 were detected in the immune-complex immunoprecipitated with
anti-TSKS serum. Panel 5 shows an autoradiograph of immune complexes (as described in panels 3 and 4) immunoprecipitated with either anti-TSKS (IP-TSKS) or rat normal serum
(Rat IP-control) and subsequently incubated with [32P]γATP in an in vitro kinase assay. A common kinase, casein kinase 2 (CKII) and several common kinase substrates including
casein, myelin basic protein (MBP) and histone 3were added to the reactions as the positive control. In immunoprecipitates with anti-TSKS sera, TSKSwas strongly phosphorylated as
well as a ~40 kDa protein, while no proteins were phosphorylated in immunoprecipitates with control normal rat sera. The ~40 kDa protein may represent autophosphorylation of
TSSK1 and/or TSSK2 or the truncated form of TSKS. Addition of CKII did not result in any additional phosphorylation. Casein, MBP and histone3 were also phosphorylated by the
kinases in the precipitated complex, whereas these proteins were not phosphorylated in the controls immunoprecipitated by normal sera.
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truncated TSKS.
Addition of CKII did not result in any additional phosphorylation,
indicating either that phosphorylation of TSKS and TSSK is saturated
or that they are not substrates of CKII. Casein, MBP and histone3 were
also phosphorylated by the kinases in the precipitated complexes
(pointed by arrows), whereas these proteins were not phosphorylated
in the controls immunoprecipitated by the normal sera. This kinase
assay provides a method to screen for inhibitors of TSKS phosphor-
ylation as well as demonstrating that casein, MBP and histone 3 may
be used as alternative substrates for TSSK1 and 2.
Identiﬁcation of the site of TSKS phosphorylation by IMAC-LC-MS/MS
Immune complexes (as described in Fig. 8) immunoprecipitatedwith
anti-TSKS (IP-TSKS) from mouse testis protein extracts were submitted
for phosphopeptide mapping by IMAC-LC-MS/MS. The TSKS phospho-
peptide HGLSPATPIQGCSGPPGS⁎PEEPPR was identiﬁed, with serine 281
(residue number based on NM_011651) followed by a proline found to
be phosphorylated. Serine 281 represented an in vivo phosphorylation
site since it was detected directly from the immunoprecipitate of the
testis tissue. Also serine 281 was one of the phosphorylation sites
predicted by Netphos 2.0 software with a high conﬁdence score.
Discussion
Analysis of the Tssk1 and 2 targeted deletion
Our mating results with chimeric males are similar to previous
observations of haploinsufﬁciency in the cases of gene deletions
affecting testis genes Klhl10, Pf20 (Spag16), Cyp17, and Prm1 or Prm2
(Zhang et al., 2004; Liu et al., 2005; Yan et al., 2004; Cho et al., 2001). In
the case of the Klhl10 gene, 47 male chimeras were produced; 16 HPC
males were infertile, and 26 LPC only produced black offspring (Yan et
al., 2004).
In the Prm1 or Prm2 targeted deletions, 51 male chimeras and 71
male chimeras were obtained, respectively, none of which producedagouti offspring (Cho et al., 2001). In the example of the Pf20 (Spag16)
targeted deletion, among 23 male chimeras, four males fathered only
black pups, six fathered both black and agouti offspring, and the
remaining 13 chimeric mice were infertile. Although 204 agouti mice
were obtained, none of them carried the mutant allele (Zhang et al.,
2004).
In TSSK1 and 2 haploinsufﬁciency, despite the presence of one
functional Tssk1 and 2 allele in the testes, the haploid spermatids
originating from targeted ES cells are apparently not producing
sufﬁcient TSSK1 and 2 proteins to support normal spermatogenesis
and sperm function. It is very interesting that one of the other proteins
that shows haploinsufﬁciency, PF20 (Spag16), is an axonemal protein
which has been localized to the ﬂagellum (Zhang et al., 2004; Zhang et
al., 2006), andwas recently shown by our team to be a TSSK2 substrate
(Zhang et al., 2008). Together these studies strongly implicate the
TSSK1 and 2 pathway and the TSSK2 substrate PF20 (Spag16) as
essential genes for fertility.
Mouse Tssk1 and 2 are located on chromosome 16 in a region that
is syntenic to a locus on human chromosome 22q11 which was
previously thought to be associated with the DiGeorge syndrome. The
human chromosomal region contains TSSK2 but not TSSK1. To create
potential mouse models of DiGeorge syndrome, two research groups
generated “large” 150 kb and 550 kb targeting deletions within the
putative DiGeorge syndrome related region, which included mouse
Tssk1 and 2 and several other genes. Homozygous animals bearing
deletions of both these areas on chromosome 16 were embryo lethal
(Puech et al., 2000; Kimber et al., 1999). It was discovered later that
Tbx1, which does not locate in these 150 kb and 550 kb regions, is
responsible for cardiovascular defects in velo-cardio-facial/DiGeorge
syndrome (Merscher et al., 2001). It is noteworthy that the two
research groups mentioned above were able to generate chimeric
mice and heterozygotes when they mated mice with these “large”
deletions containing mouse Tssk1 and 2. This stands in contrast to our
ﬁndings that deletion of Tssk1 and 2 alone prevents transmission of
the Tssk1 and 2 mutant allele from chimeric males to offspring. A
similarly puzzling result has been observed in the case of the deletion
of the mouse Cyp17 (Cytochrome P450 17-Hydroxylase/17,20 Lyase)
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consistently failed to generate heterozygous Cyp17mice, and after ﬁve
matings chimeric mice stopped mating indicating a change in sexual
behavior (Liu et al., 2005). At the same time, another research group
reported that they were able to generate chimeric mice and
heterozygotes that were reproductively normal, but Cyp17−/− zygotes
died by embryonic day 7 (Bair and Mellon, 2004).
Haploinsufﬁciency of the Tssk1 and 2 genes implies that the dose
of these germ cell genes is critical to spermatogenesis. A single dose of
these genes may not be sufﬁcient to fulﬁll the full gene function,
especially in certain genetic backgrounds. Therefore, it is reasonable to
posit that the dose of a certain germ cell gene may be more critical in
some mouse strains than in others in which the same gene may
effectively be transmitted. The two research groups which conducted
the deletion of large fragments of chromosome 16 used WW6 ES cells
(Merscher et al., 2001; Puech et al., 2000) and TC1 ES cells respectively
(Kimber et al., 1999), while we used the 129Svj ES cells to conduct our
targeted deletions. Thus, different mouse strains and different
targeting strategies may explain the different effects on fertility.
Nevertheless, our extensive mating experiments, and careful analysis
on genotype and phenotype of Tssk1 and 2 chimeric mice indicate that
the dose of TSSK1 and 2 must be essential for normal male fertility.
Expression, localization, interaction and functional activation of TSSK2
and TSKS
Western blot analyses identiﬁed TSSK2 and TSKS in testes and
mature sperm of both mice and men. Microscopic studies immuno-
localized TSSK2 and TSKS proteins in spermatids and spermatozoa (Xu
et al. 2008, the companion paper). In situ analysis indicated that
mRNAs for these proteins are mainly expressed in post-meiotic
spermatids (Xu et al. 2008, the companion paper). In addition, high-
throughput cDNA array data regarding gene expression in the testis
during the progression of spermatogenesis are available now online:
http://www.mrg.genetics.washington.edu/. Consistent with our in
situ result, the cDNA array analysis showed that Tssk1 and 2 and Tsks
mRNA expression is speciﬁc to spermatids. These expression and
localization data are consistent with the phenotype of arrested
spermiogenesis noted in testes of chimeric Tssk 1 and 2 mice.
To dissect the function of TSSK2 kinase, it is important to under-
stand the interaction of this enzymewith itsmajor substrate TSKS. Our
co-immunoprecipitation experiments demonstrated that both rabbit
anti-TSSK2 and rat anti-TSKS were capable of immunoprecipitating
complexes from human sperm as well as from mouse testes that
contained both the enzyme and its substrate. Theseﬁndings conﬁrmed
that interactions of this kinase/substrate pair occur in both testis and
sperm in different species. Our analysis of TSKS deletion mutants
revealed that theN-terminus of TSKS is essential for TSSK2binding and
thus contains the critical interaction site. In our companion paper
(Xu et al, 2008), we discovered TSKS concentrated in spermatid
centrioles during ﬂagellogenesis, while TSSK2 partially co-localized at
the same region with additional localization at the sperm tail,
acrosomal region of mouse sperm and equatorial segment of human
sperm. The strongbindingactivity betweenTSSK2andTSKSmaybe the
driving force to recruit TSSK2 to the sites around the centrioles,
suggesting that TSSK2/TSKS may have a role in centriolar function
during ﬂagellogenesis. This is also consistent with the phenotype of
arrested spermiogenesis in testes of chimeric Tssk1 and 2. TSSK2 had a
wider subcellular localization thanTSKS, so it is alsopossible thatTSSK2
has other substrates, and may have functions beyond the centriolar
region that affect the phenotype of chimeric Tssk1 and 2 animals.
Most importantly, our experiments indicated that TSSK2 kinase is
enzymatically active in both testis and mature sperm. In vitro kinase
experiments conﬁrmed that TSSK2 recovered in immunoprecipitates
from human sperm and mouse testes was capable of phosphorylating
TSKS and itself. The TSKS phosphopeptide HGLSPATPIQGCSGPPG-S⁎PEEPPR was identiﬁed, with serine 281 followed by a proline found
to be phosphorylated in vivo. Serine 281 was one of the phosphoryla-
tion sites predicted by Netphos 2.0 software with a high conﬁdence
score. This phosphorylation site, located between two coiled-coil
domains, is conserved in both mouse and human TSKS. However, it is
likely that there are multiple phosphorylation sites on TSKS, because
multiple immunoreactive TSKS spotswere detected in the charge train
in 2-D Western analysis (Fig. 5C), and the Netphos 2.0 predicted
multiple high probability phosphorylation sites. In our companion
paper (Xu et al, 2008), we further discussed several kinase/substrate
pairs that play important roles in somatic centrosome function. The
infertile phenotype of mice bearing targeted deletion of Tssk1 and 2
suggests an essential role for TSSK2/TSKS in spermatid centriole
functions and underscores the contraceptive target candidacy of this
ﬁrst kinase/substrate pair detected in the gamete centriole.
Previous studies of TSSK2 reported the presence of this enzyme in
testis (Kueng et al., 1997). The conﬁrmation in the present study of the
persistence of this enzyme in sperm in humans and mice opens the
possibility of considering TSSK 1 and 2 as targets for both a male
contraceptive that acts on the testis as well as for an intra-vaginal
spermicidal agent.
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